Archives of internal medicine · 1999
Newer drug therapy for congestive heart failure.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Coodley E
Аннотация
BACKGROUND: The management of congestive heart failure has undergone a number of modifications over the past 5 to 10 years.
METHODS: These include assaying the role of inotropic drugs, evaluating the role of phosphodiesterase inhibitors, considering the role of intermittent inotropic infusion in ambulatory patients, and recognizing the importance of angiotensin-converting enzyme inhibitors. Very recently, the important role of angiotensin II receptor blocking agents and the use of beta blockade have provided additional modalities for the control of congestive heart failure. The relative usefulness of such therapy has been reviewed in this article.
CONCLUSION: The management of congestive heart failure has undergone considerable change with the use of newer and more effective drugs.
METHODS: These include assaying the role of inotropic drugs, evaluating the role of phosphodiesterase inhibitors, considering the role of intermittent inotropic infusion in ambulatory patients, and recognizing the importance of angiotensin-converting enzyme inhibitors. Very recently, the important role of angiotensin II receptor blocking agents and the use of beta blockade have provided additional modalities for the control of congestive heart failure. The relative usefulness of such therapy has been reviewed in this article.
CONCLUSION: The management of congestive heart failure has undergone considerable change with the use of newer and more effective drugs.
Предметные рубрики MeSH
Adrenergic beta-AntagonistsAlgorithmsAmiodaroneAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsAnti-Arrhythmia AgentsAntihypertensive AgentsCalcium Channel BlockersCardiotonic AgentsDiagnosis, DifferentialHeart FailureHumansIndansMagnesium CompoundsMineralocorticoid Receptor AntagonistsNatriuretic Peptide, BrainPropionates